Literature DB >> 8220877

Effects of the central analgesic tramadol and its main metabolite, O-desmethyltramadol, on rat locus coeruleus neurones.

J Sevcik1, K Nieber, B Driessen, P Illes.   

Abstract

1. Tramadol is a centrally acting analgesic with low opioid receptor affinity and, therefore, presumably additional mechanisms of analgesic action. Tramadol and its main metabolite O-desmethyltramadol were tested on rat central noradrenergic neurones of the nucleus locus coeruleus (LC), which are involved in the modulation of nociceptive afferent stimuli. 2. In pontine slices of the rat brain the spontaneous discharge of action potentials of LC cells was recorded extracellularly. (-)-Tramadol (0.1-100 microM), (+)-tramadol (0.1-100 microM), (-)-O-desmethyl-tramadol (0.1-100 microM) and (+)-O-desmethyltramadol (0.01-1 microM) inhibited the firing rate in a concentration-dependent manner. (+)-O-desmethyltramadol had the highest potency, while all other agonists were active at a similar range of concentrations. 3. (-)-Tramadol (10, 100 microM) was less inhibitory in brain slices of rats pretreated with reserpine (5 mg kg-1, 5 h before decapitation) than in controls. 4. The effect of (-)-tramadol (10 microM) was abolished in the presence of the alpha 2-adrenoceptor antagonist, rauwolscine (1 microM), whilst that of (+)-O-desmethyltramadol (0.3 microM) virtually disappeared in the presence of the opioid antagonist, naloxone (0.1 microM). (+)-Tramadol (30 microM) and (-)-O-desmethyl-tramadol (10 microM) became inactive only in the combined presence of naloxone (0.1 microM) and rauwolscine (1 microM). 5. In another series of experiments, the membrane potential of LC neurones was determined with intracellular microelectrodes. (-)-Tramadol (100 microM) inhibited the spontaneous firing and hyper-polarized the cells; this effect was abolished by rauwolscine (1 microM). (+)-O-desmethyltramadol (10 microM)had a similar but somewhat larger effect on the membrane potential than (-)-tramadol. The (+)-O-desmethyltramadol-(10 microM) induced hyperpolarization was abolished by naloxone (0.1 microM).6. The hyperpolarizing effect of noradrenaline (30 microM) was potentiated in the presence of (-)-tramadol(100 microM), but not in the presence of (+)-O-desmethyltramadol (10 microM). There was no potentiation of the noradrenaline (30 microM) effect, when the cells were hyperpolarized by current injection to an extent similar to that produced by (-)-tramadol (100 microM).7. Both noradrenaline (100 microM) and (- )-tramadol (100 microM) decreased the input resistance.8. The results confirm that the analgesic action of tramadol involves both opioid and non-opioid components. It appears that (-)-tramadol inhibits the uptake of noradrenaline and via a subsequent increase in the concentration of endogenous noradrenaline indirectly stimulates alpha2-adrenoceptors. (+)-0-desmethyltramadol seems to stimulate directly opioid micro-receptors. The effects of (+)-tramadol and(-)-O-desmethyltramadol consist of combined micro-opioid and alpha2-adrenergic components.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8220877      PMCID: PMC2175982          DOI: 10.1111/j.1476-5381.1993.tb13788.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  Synaptic potentials in rat locus coeruleus neurones.

Authors:  E Cherubini; R A North; J T Williams
Journal:  J Physiol       Date:  1988-12       Impact factor: 5.182

Review 2.  Receptor interactions at noradrenergic neurones.

Authors:  P Illes; H D Weber; J Neuburger; B Bucher; J T Regenold; W Nörenberg
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

Review 3.  Modulation of transmitter and hormone release by multiple neuronal opioid receptors.

Authors:  P Illes
Journal:  Rev Physiol Biochem Pharmacol       Date:  1989       Impact factor: 5.545

Review 4.  The descending noradrenergic system and analgesia.

Authors:  Y Kuraishi; M Satoh; H Takagi
Journal:  Pain Headache       Date:  1987

5.  Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids.

Authors:  H H Hennies; E Friderichs; J Schneider
Journal:  Arzneimittelforschung       Date:  1988-07

6.  Inhibitory adenosine A1-receptors on rat locus coeruleus neurones. An intracellular electrophysiological study.

Authors:  J T Regenold; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

7.  Effects of tramadol on motor and sensory responses of the spinal nociceptive system in the rat.

Authors:  K H Carlsson; I Jurna
Journal:  Eur J Pharmacol       Date:  1987-07-02       Impact factor: 4.432

8.  Blockade of alpha 2-adrenoceptors increases opioid mu-receptor-mediated inhibition of the firing rate of rat locus coeruleus neurones.

Authors:  P Illes; W Nörenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-11       Impact factor: 3.000

9.  Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.

Authors:  R B Raffa; E Friderichs; W Reimann; R P Shank; E E Codd; J L Vaught
Journal:  J Pharmacol Exp Ther       Date:  1992-01       Impact factor: 4.030

10.  Inhibition of spinal nociceptive transmission from the midbrain, pons and medulla in the rat: activation of descending inhibition by morphine, glutamate and electrical stimulation.

Authors:  S L Jones; G F Gebhart
Journal:  Brain Res       Date:  1988-09-20       Impact factor: 3.252

View more
  10 in total

Review 1.  The role of tramadol in cancer pain treatment--a review.

Authors:  Wojciech Leppert; Jacek Łuczak
Journal:  Support Care Cancer       Date:  2004-11-18       Impact factor: 3.603

Review 2.  Tramadol: a review of its use in perioperative pain.

Authors:  L J Scott; C M Perry
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

3.  Inhibition of bladder overactivity by a combination of tibial neuromodulation and tramadol treatment in cats.

Authors:  Fan Zhang; Abhijith D Mally; P Dafe Ogagan; Bing Shen; Jicheng Wang; James R Roppolo; William C de Groat; Changfeng Tai
Journal:  Am J Physiol Renal Physiol       Date:  2012-04-11

Review 4.  Revisiting Tramadol: A Multi-Modal Agent for Pain Management.

Authors:  Ahmed Barakat
Journal:  CNS Drugs       Date:  2019-05       Impact factor: 5.749

5.  The Effect of Orexin-2 and Endocannabinoid-1 Antagonists on Neuronal Activity of Hippocampal CA1 Pyramidal Neurons in Response to Tramadol in Rats.

Authors:  Vajihe Imanpour; Parham Reisi
Journal:  Adv Biomed Res       Date:  2022-03-30

6.  Actions of tramadol on micturition in awake, freely moving rats.

Authors:  Raj Kumar Pandita; Rikard Pehrson; Thomas Christoph; Elmar Friderichs; Karl-Erik Andersson
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

7.  Acute Tramadol-Induced Cellular Tolerance and Dependence of Ventral Tegmental Area Dopaminergic Neurons: An In Vivo Electrophysiological Study.

Authors:  Shabnam Khodayari; Firouz Ghaderi Pakdel; Parviz Shahabi; Somayyeh Naderi
Journal:  Basic Clin Neurosci       Date:  2019-05-01

8.  Evaluation of antidepressant activity of tramadol in mice.

Authors:  Vandana Tayal; Bhupinder Singh Kalra; Shalini Chawla
Journal:  Indian J Pharmacol       Date:  2008-06       Impact factor: 1.200

9.  Antidepressant-like activity of tramadol in mice.

Authors:  Bhupinder Singh Kalra; Vandana Tayal; Shalini Chawla
Journal:  Indian J Psychiatry       Date:  2008-01       Impact factor: 1.759

10.  A Systematic Review of Laboratory Evidence for the Abuse Potential of Tramadol in Humans.

Authors:  Kelly E Dunn; Cecilia L Bergeria; Andrew S Huhn; Eric C Strain
Journal:  Front Psychiatry       Date:  2019-09-26       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.